Alicia Santos Savio

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Sustained IL-2R signaling of limited duration by high-dose mIL-2/mCD25 fusion protein amplifies tumor-reactive CD8+ T cells to enhance antitumor immunity”.

Sustained IL-2R signaling of limited duration by high-dose mIL-2/mCD25 fusion protein amplifies tumor-reactive CD8+ T cells to enhance antitumor immunity

Cancer Immunology Immunotherapy(2020)10.1007/s00262-020-02722-5

N/A

0DataRank · unranked

15 citations

Kevin H. Toomer, Janika Põder, Alicia Santos Savio, Sunnie Hsiung, Thomas R. Malek +1 more

High-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4+ and CD8+ neoantigen-specific T cells to promote antitumor immunity

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002865

N/A

0DataRank · unranked

32 citations

Kathryn M LaPorte, Sunnie Hsiung, Alicia Santos Savio, Thomas R. Malek, Rosmely Hernandez

Robust IL-2-dependent antitumor immunotherapy requires targeting the high-affinity IL-2R on tumor-specific CD8+ T cells

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-006611

N/A

0DataRank · unranked

31 citations

Rosmely Hernandez, Alicia Santos Savio, Thomas R. Malek, Kathryn M LaPorte